Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Retrospective Observational Study
UPH during first-line GnP is an independent adverse prognostic factor in patients with unresectable PC, even after accounting for TVC. In pancreatic head cancer, closer monitoring for biliary and obstructive complications may be particularly important during treatment.
Authors
- Yu Sekine (ORCID: https://orcid.org/0009-0007-8734-4998)
- Hiroshi Ohyama (ORCID: https://orcid.org/0000-0003-0614-581X)
- Mayu Ouchi (ORCID: https://orcid.org/0009-0006-4794-8239)
- T. Takahashi
- S. Takano
- Miho Sakai
- Masayuki Ohtsuka (ORCID: https://orcid.org/0000-0002-5091-1078)
- Kazuki Watabe (ORCID: https://orcid.org/0009-0003-9501-6928)
- Jun Kato (ORCID: https://orcid.org/0000-0003-4832-8024)
- N. Sakai
- Akiko Abe (ORCID: https://orcid.org/0000-0003-4984-0273)
- Motoyasu Kan (ORCID: https://orcid.org/0000-0001-8481-4551)
- Yoshiki Ogane (ORCID: https://orcid.org/0009-0001-5467-054X)
- Sodai Uchida (ORCID: https://orcid.org/0009-0002-5902-9230)
- Izumi Ohno
- Yoshiki Nakaya (ORCID: https://orcid.org/0009-0006-1452-3322)
- Koki Yokozuka
- Taiga Sudo (ORCID: https://orcid.org/0009-0000-0938-351X)
- Hiroki Kurosaki (ORCID: https://orcid.org/0009-0009-7925-2748)
- Tsukasa Takayashiki
Institutions
- Chiba University (JP)
Publication Details
- Journal
- Cancers
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3390/cancers18020194
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00